{"protocolSection":{"identificationModule":{"nctId":"NCT01612585","orgStudyIdInfo":{"id":"RSCMI-Ⅴ"},"secondaryIdInfos":[{"id":"RSCMI-Ⅴ"}],"organization":{"fullName":"China Academy of Chinese Medical Sciences","class":"OTHER"},"briefTitle":"Safety Study of Dengzhanxixin (a Chinese Medicine Injection) Used in Hospitals in China","officialTitle":"A Registry Study on Safety Surveillance of Dengzhanxixin (a Chinese Medicine Injection) Used in China"},"statusModule":{"statusVerifiedDate":"2012-06","overallStatus":"UNKNOWN","lastKnownStatus":"ACTIVE_NOT_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2012-04"},"primaryCompletionDateStruct":{"date":"2014-12","type":"ESTIMATED"},"completionDateStruct":{"date":"2015-12","type":"ESTIMATED"},"studyFirstSubmitDate":"2012-06-03","studyFirstSubmitQcDate":"2012-06-03","studyFirstPostDateStruct":{"date":"2012-06-06","type":"ESTIMATED"},"lastUpdateSubmitDate":"2012-06-07","lastUpdatePostDateStruct":{"date":"2012-06-11","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Yanming Xie","investigatorTitle":"Deputy Director","investigatorAffiliation":"China Academy of Chinese Medical Sciences"},"leadSponsor":{"name":"China Academy of Chinese Medical Sciences","class":"OTHER"},"collaborators":[{"name":"Guangdong Provincial Hospital of Traditional Chinese Medicine","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"This study was advocated by Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences in October 2011.\n\nIt was funded by China major scientific and technological specialized project for 'significant new formulation of new drugs'.\n\nDengzhanxixin is kind of Chinese Medicine injection used for treating Ischemic Stroke and coronary heart disease in many Chinese hospitals.\n\nThe purpose of this study is to determine adverse drug events or adverse drug reaction in large sample size 30,000 patients.","detailedDescription":"It is very common that Chinese Medicine Injection used in hospitals in mainland China. However safety problems rose in recent years. There could be many uncertain factors influence Chinese Medicine Injection in clinical practice.\n\nSafety surveillance on Chinese Medicine injection is an important problem that needs to be sorted out through large sample observational study.\n\nA registry study for Kudiezi injection safety surveillance with 30000 patients will be conducted from April.2012 to December.2014.\n\nEligibility criteria Patients who will use Dengzhanxixin injection in selected hospitals\n\nData will be collected in three aspects by three different forms as following:\n\nForm A (green): demographic information ；Form B (pink): adverse drug events/reaction； Form C (white): extracted information from hospital information system and laboratory information system Form"},"conditionsModule":{"conditions":["Ischemic Stroke","Coronary Heart Disease"]},"designModule":{"studyType":"OBSERVATIONAL","designInfo":{"observationalModel":"COHORT","timePerspective":"RETROSPECTIVE"},"enrollmentInfo":{"count":30000,"type":"ESTIMATED"}},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of participants with adverse events; incidence of Dengzhanxixin's ADRs and identify factors that contributed to the occurrence of the adverse reaction.","description":"All patients will be measured and assessed at the time Dengzhanxixin is administered to them until they discharge. Patients using Dengzhanxixin will be registered on a registration form including disease background, Dengzhanxixin's administration, and extraction information from hospital information system. An adverse event or drug adverse reaction form also will be used to describe any doubted symptoms or signs from patients. A judgment will be made by doctors directly and a further analysis will be conducted by researchers to decide those potential side effects of Dengzhanxixin.","timeFrame":"The registry procedure will last 3 years only for patients using Dengzhanxixin"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients using Dengzhanxixin injection from 2012 to 2014\n\nExclusion Criteria:\n\n* none","healthyVolunteers":false,"sex":"ALL","stdAges":["CHILD","ADULT","OLDER_ADULT"],"studyPopulation":"An anticipated sample size was caculated in this study, about 30000. Patients using Kudiezi injection from 2012 to 2014 in more than 30 hospitals","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"overallOfficials":[{"name":"Yan M Xie, BA","affiliation":"Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences","role":"PRINCIPAL_INVESTIGATOR"}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000003327","term":"Coronary Disease"},{"id":"D000003324","term":"Coronary Artery Disease"},{"id":"D000017202","term":"Myocardial Ischemia"}],"ancestors":[{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000020521","term":"Stroke"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000001161","term":"Arteriosclerosis"},{"id":"D000001157","term":"Arterial Occlusive Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M6236","name":"Coronary Artery Disease","asFound":"Coronary Heart Disease","relevance":"HIGH"},{"id":"M6239","name":"Coronary Disease","asFound":"Coronary Heart Disease","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M19196","name":"Myocardial Ischemia","asFound":"Coronary Heart Disease","relevance":"HIGH"},{"id":"M9109","name":"Heart Diseases","asFound":"Heart Disease","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M4159","name":"Arteriosclerosis","relevance":"LOW"},{"id":"M4155","name":"Arterial Occlusive Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}